3rd Quarter - Termination

CAPITOL HILL CONSULTING GROUP for UNITED STATES PHARMACOPEIAL CONVENTION (USP)

Firm
Client
Income
$20,000
Expenses
—
Terminated
Aug 31, 2022

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Maintaining US support for quality pharmaceutical standards. Issues related to coronavirus, including drug and supply chain safety. Issues related to continuous manufacturing.

LobbyistCovered position, as disclosed
BRIAN SUTTER Staff Dir. W&M Health subcommittee, Chairman Dave Camp April'13-Dec'14. Professional Staff, W&M Health subcommittee, Chairman Dave Camp, Jan'11-April'13. Leg Dir. Rep Dave Camp, May'08-Jan'11. Leg Asst Rep Dave Camp, Feb'03-May'08. Staff Ast July'02
EMILY ELIZABETH WILKINSON-HOLLAND New Staff -Rep. Price (2010-11), LA: Rep. Grimm (2011-12), Rep. Black (2012-13), Sen.Vitter (2013-2015), Sen. Heller (2015-17), Policy Adv. to the Sec.- Dept of HHS (3/2017-8/2017), Sr Advisor to Administrator - Ctrs for Medicare & Medicaid (8/17- 5/19)

Contacted: Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.